Skip links
Companies
› Denmark › LEO PHARMA A/S
Company registry profile
LEO PHARMA A/S logo

LEO PHARMA A/S

Private limited company (Ltd.) Active

in

From the registry

Registration details

Registration No.
56759514
Incorporation Date
1962-02-10
Company Type
Not disclosed
Address
Ballerup, Denmark
Website
www.leo-pharma.com/
Status
Active
Country
Denmark
Source: Danish Business Authority β€” CVR (Central Business Register)Registry coverage
Registry summary

Company overview

LEO Pharma A/S is a private limited company (Aktieselskab) registered in Denmark under CVR (Central Business Register) number 56759514. The company was incorporated on 10 February 1962 and is currently recorded with active status in the Danish Business Authority’s CVR register. Its registered address is Industriparken 55, 2750 Ballerup, Denmark.

LEO Pharma A/S is a pharmaceutical company focused on medical dermatology. It researches, develops, manufactures and markets prescription and over-the-counter treatments for skin conditions, including psoriasis, actinic keratosis and other inflammatory and chronic dermatological diseases, alongside a legacy portfolio addressing other specialty conditions. LEO Pharma operates through a global network of affiliated entities and distributes its products in more than 100 countries, with manufacturing and commercial operations spanning Europe, North America and Asia-Pacific.

LEO Pharma A/S is not listed on any stock exchange and has no publicly traded shares or ticker symbol.

Based on published 2024 annual results covering the wider LEO Pharma organisation, consolidated group revenue reached DKK 12,453 million for the 2024 financial year, a reported 10% increase at constant exchange rates, with adjusted EBITDA of DKK 895 million and a net loss of DKK 1,776 million, narrower than the DKK 3,607 million loss reported for 2023. The wider organisation reported approximately 4,000 employees operating in over 100 countries as of the 2024 financial year. These figures reflect consolidated results reported for the LEO Pharma group and should not be read as standalone financial statements for the Danish legal entity LEO Pharma A/S.

No dissolution date is recorded for the company, and no material recent regulatory filings specific to the legal entity were identified beyond the group-level annual results referenced above.

Data Provenance
This record is sourced directly from official government registries, including Danish Business Authority β€” CVR (Central Business Register).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Shareholders of LEO Pharma A/S

Two shareholders are disclosed for LEO Pharma A/S in the Danish CVR register (Central Business Register), with ownership data verified as of 14 September 2026:

  • LEO Holding A/S (Denmark) β€” 81.77% of ordinary shares
  • Cidron Savanna 4 SARL β€” 18.23% of ordinary shares

Both interests are recorded as direct holdings of ordinary shares. LEO Holding A/S is linked, in CVR-derived corporate data, upward to Leo Fondet (the LEO Foundation, registration number DK 11623336), a Danish enterprise foundation established in 1984 to secure the long-term continuation of LEO Pharma. LEO Foundation’s own "Ownership" page and LEO Pharma’s corporate website both describe the LEO Foundation as holding approximately 80% of LEO Pharma, consistent with the CVR-recorded stake held indirectly through LEO Holding A/S.

Cidron Savanna 4 SARL’s 18.23% holding is consistent in size and timing with the minority stake acquired by Nordic Capital, a European private-equity investor. The LEO Foundation and Nordic Capital announced this transaction in March 2021 and confirmed its closing in July 2021, for a stated investment of EUR 450 million, describing the resulting position as an "active minority ownership" of approximately 20%. The CVR register itself only discloses the shareholder name Cidron Savanna 4 SARL and does not state that this entity is a Nordic Capital vehicle, so the correspondence with Nordic Capital’s investment should be treated as a reasonable inference from public deal disclosures rather than a registry-confirmed fact.

Ultimate beneficial ownership

The Danish CVR register separately records two individuals β€” Karin Jexner Hamberg and Anja Boisen β€” under the "Reelle ejere" (beneficial owners) designation for LEO Pharma A/S, both with active status in the data reviewed. No effective ownership percentage is disclosed for either individual, and the register extract does not state the basis (board control versus capital ownership) for the designation. Because LEO Pharma A/S’s majority shareholder chain leads to an enterprise foundation (Leo Fondet) rather than a natural person, a UBO designation based on governance or control criteria rather than a calculable capital percentage is plausible, but this could not be independently confirmed from other authoritative sources in this review. No effective ownership percentage is calculated because none is reported.

Data availability

Direct shareholder information is major-shareholder-only and current, sourced from the Danish CVR register as of 14 September 2026. Beneficial-owner information is partial: two individuals are registered but without disclosed percentages or a stated ownership basis.

Sources

  • Danish Business Authority β€” CVR (Central Business Register), https://datacvr.virk.dk, register data synced 15 September 2026
  • LEO Pharma Global, "Ownership," https://leo-pharma.com/ownership/, retrieved 16 September 2026
  • LEO Foundation, "Ownership," https://leo-foundation.org/en/ownership/, retrieved 16 September 2026
  • Nordic Capital, "LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology," https://www.nordiccapital.com/insights/press-releases/leo-foundation-and-nordic-capital-partner-up-to-further-strengthen-leo-pharma-s-leading-position-in-medical-dermatology/, published 23 March 2021
  • LEO Foundation, "The LEO Foundation announces closing of Nordic Capital’s investment in LEO Pharma," https://leo-foundation.org/en/2021/07/22/the-leo-foundation-announces-closing-of-nordic-capitals-investment-in-leo-pharma/, published 22 July 2021

Swipe or scroll for more columns

Shareholder Type Holding Source Document
LEO Holding A/S 81.8% Danish Business Authority β€” CVR (Central Business Register)

Officers

82

Directors and officers of LEO Pharma A/S

The Danish CVR register holds 82 officer-related records for LEO Pharma A/S; the data extract available for this profile includes five records, all currently active with no resignation date recorded. Disclosed roles among these five include Chairman of the Board ("Formand") and Board Member ("Bestyrelsesmedlem"). Two further individuals in the same extract are recorded under the separate "Reelle ejere" (beneficial owner) designation rather than as directors or officers and are addressed in the shareholders/UBO section of this profile instead.

Jesper Brandgaard is recorded as Chairman of the Board of Directors ("Formand") in the CVR extract. This is corroborated by LEO Pharma’s and the LEO Foundation’s own announcements, which state that Jesper Brandgaard β€” previously Group CFO of Novo Nordisk for more than 17 years β€” became Chairman of LEO Pharma’s Board of Directors effective 1 August 2021.

Aage Spang-Hanssen and Carl-Aage Lund are recorded as Board Members ("Bestyrelsesmedlem") in the CVR register, both with active status. No independent secondary source was located to corroborate these two specific appointments beyond the CVR register itself.

Nationality is not disclosed for any individual in the reviewed CVR extract. A correspondence address is recorded in Denmark for two of the individuals; this is treated strictly as a service address and not as evidence of nationality or residence.

LEO Pharma’s own corporate website separately identifies Christophe Bourdon as Chief Executive Officer, effective 1 April 2022, previously CEO of Orphazyme A/S. This appointment could not be cross-matched to a specific record within the five-record CVR extract available (out of 82 total) and is included here for completeness based on the company’s own governance disclosures.

Recent officer changes

  • Jesper Brandgaard appointed Chairman of the Board of Directors, effective 1 August 2021 (source: LEO Foundation).
  • Christophe Bourdon appointed Chief Executive Officer, effective 1 April 2022 (source: LEO Pharma corporate website).

Data availability

Officer information for LEO Pharma A/S is partial: the CVR register holds 82 officer-related records for the company, but only five were available in the data extract reviewed, and historical (resigned/former) officers were not included. Nationality is not disclosed in the reviewed CVR data for any listed individual.

Sources

  • Danish Business Authority β€” CVR (Central Business Register), https://datacvr.virk.dk, register data synced 15 September 2026
  • LEO Foundation, "Jesper Brandgaard new Chairman of the Board of Directors of LEO Pharma," https://leo-foundation.org/en/2021/07/01/jesper-brandgaard-new-chairman-of-the-board-of-directors-of-leo-pharma/, published 1 July 2021
  • LEO Pharma, "LEO Pharma appoints Christophe Bourdon as new CEO," https://www.leo-pharma.com/media-center/news/leo-pharma-appoints-christophe-bourdon-as-new-ceo, retrieved 16 September 2026
  • LEO Pharma, "Jesper Brandgaard," Board of Directors biography, https://www.leo-pharma.com/who-we-are/our-governance/board-of-directors/jesper-brandgaard, retrieved 16 September 2026

Registry feed — rows exactly as filed with Danish Business Authority β€” CVR (Central Business Register), including entries the profile above does not cover.

AS
Aage Spang-Hanssen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

KJ
Karin Jexner Hamberg ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Reel Ejer

AB
Anja Boisen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Reel Ejer

JB
Jesper Brandgaard ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Formand

CL
Carl-aage Lund ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

FF
Fie Falck Bruus Madsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

PH
PER HAKON SCHMIDT ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

PH
Peter Helt Jacobsen Haahr ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

AB
Ann Berit Sveigaard ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

NS
Niels Smidt Rastrup Andersen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JH
JESPER HOILAND ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

HB
Hans Bang ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

GM
Gorm Milan Thamsborg ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

CC
Carthon Christoffer Cecil Valdemar Nyholm Treschow ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Formand

HA
Hanne Ann-dorthe Ginderskov ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

EF
Erling Finn Juhl Nielsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

PB
Poul Bo Kilund ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

PH
Philip Harald Eickhoff ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
DirektΓΈr

BJ
Brian Juel Pedersen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JB
Judith Blankholm ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

AS
Arne Stolting ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

LK
Lars Kjoller ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

KB
Karin Bredal Jensen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

SC
Signe Christensen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JB
Jens Bo Olesen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JV
Jens Vallentin Holm ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

AE
Anna Elisabeth Gundersen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JM
Jesper Moller Hougaard ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

RR
Rifat Ramicevic ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

LJ
Louisa Jacobsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

LG
Lars Green ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

PN
Peder Nielsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

EL
Ernst Lunding ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Formand

MB
Mette Bonde Eliasson ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

JR
Jan Rasmussen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

PR
Poul Rodbroe Rasmussen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Formand

TE
Thorsten Erik Ramsing ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

MD
Morten Drewes Pedersen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

MR
Morten Ryskjær ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

PS
Peter Schwarz ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Reel Ejer

GK
Grethe Karin Hansen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

HA
Henrik Andersson ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JP
Jukka Pekka Pertola ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

IJ
Irene Jonassen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

KL
Klaus Legau ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

AE
Axel Emil Jacobsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Revision

JK
Jannie KogsbΓΈll ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

NS
Nina SΓΆlver Henning ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JH
JORGEN HALSTEEN ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
DirektΓΈr

IS
Ingelise Saunders ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

HN
Helmuth Nielsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Formand

CP
Cristina Patricia Lage ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

KA
Karin Attermann ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

LH
Lotte Hjortshoj ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

EH
Erik Hansen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
DirektΓΈr

FM
Franck Mareno ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

ED
Eivind Drachmann Kolding ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Reel Ejer

VJ
Vilhelm Johannes Kahlke ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

SI
Sammy Islam Al-moalem ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

MO
Marianne Olesen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

AV
Arne Victor Hansen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

AS
Anders SPOHR ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
DirektΓΈr

IS
Ingelise Sorensen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

JS
Jane Stymne Goransson ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

LO
Lars Olsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

AK
Anders Kronborg ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Adm. Dir.

JM
Jesper Mailind ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

SM
Sara Melissa Plov Hoff ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

VO
Vagn Ole Godtfredsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

PD
Patrik Dahlen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

JR
Jette Rattenborg Thomsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

LB
Laurids Bonne Bjornshauge ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

AC
Allan Carsten Dahl ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

GP
GITTE PUGHOLM AABO ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

FL
Fie Larsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

JC
John Carsten Mehlbye ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Bestyrelsesmedlem

CT
Catherine Therese Jeanne Mazzacco ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Adm. Dir.

BV
Berit Van Arkens ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

CD
Christophe Dominique Luc Charles Bourdon ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Adm. Dir.

TC
Thomas Christian Facius ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

BP
Birgitte Pryds ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

KM
Kreesten Madsen ACTIVE

Residence
πŸ‡©πŸ‡° Denmark
Occupation
Suppleant

Group Structure

Group structure of LEO Pharma A/S

LEO Pharma A/S is part of a verified corporate group headed by Leo Fondet (the LEO Foundation), a Danish enterprise foundation (registration number DK 11623336) established in 1984. Danish CVR-linked registry data and the LEO Foundation’s own published disclosures identify the Foundation as the ultimate parent and majority owner of the group, holding its interest in LEO Pharma A/S indirectly through the intermediate holding company LEO Holding A/S (registration number DK 39122251), which is the immediate parent recorded for LEO Pharma A/S. A minority interest of 18.23% in LEO Pharma A/S is held directly by Cidron Savanna 4 SARL, understood β€” based on the timing and size of Nordic Capital’s publicly announced 2021 minority investment in LEO Pharma β€” to be linked to Nordic Capital, though this specific entity link is not itself confirmed in the CVR register or in Nordic Capital’s public disclosures.

Beneath LEO Pharma A/S, CVR-linked corporate data records a substantial number of affiliated entities operating in numerous jurisdictions, including Norway, Ireland, the United States, Italy, Japan, the Czech Republic, Slovakia, Belgium, China, the United Kingdom, Switzerland, Canada, Sweden, Austria, the Netherlands, Spain, Greece, South Korea, Finland, Australia, New Zealand, Turkey, Mexico, Germany, France, Russia and Portugal, reflecting LEO Pharma’s stated commercial and manufacturing presence in over 100 countries. Registered names generally follow the "LEO Pharma" or "Leo Pharma" naming pattern (for example, LEO Laboratories Limited in Ireland and the UK, LEO Pharma Inc. in the US and Canada, and LEO Pharma GmbH in Germany). Because this linkage data was not individually cross-verified against each country’s own registry, these entities are classified as affiliates rather than as confirmed direct or indirect subsidiaries.

The corporate-linkage data underlying this structure was synced from company registry sources on 15 September 2026. Ownership percentages for individual downstream affiliates are not disclosed in the available data.

Verified corporate relationships

Entity Country Registration number Relationship Ownership Status Information date
Leo Fondet (LEO Foundation) DK DK 11623336 Ultimate parent Ownership percentage not disclosed Active 2026-09-15
LEO Holding A/S DK DK 39122251 Immediate parent Ownership percentage not disclosed Active 2026-09-15
Cidron Savanna 4 SARL Not disclosed Not disclosed Direct minority shareholder 18.23% Active 2026-09-14
LEO Laboratories Limited IE IE 16885 Affiliate Ownership percentage not disclosed Active 2026-09-15
LEO Pharma Inc. US US NJ 4724539 Affiliate Ownership percentage not disclosed Active 2026-09-15
LEO Pharma GmbH DE DE 63065B11088 Affiliate Ownership percentage not disclosed Active 2026-09-15

Recent structural changes

  • Nordic Capital completed a minority investment in LEO Pharma, closing 22 July 2021, alongside the LEO Foundation’s continued majority ownership (source: LEO Foundation).
  • Jesper Brandgaard’s appointment as Chairman of the Board followed the Nordic Capital transaction, effective 1 August 2021.

Data availability

Group structure information is partial. The immediate and ultimate parent are identifiable through CVR-linked registry data and are corroborated by official LEO Foundation and Nordic Capital disclosures, but ownership percentages for downstream affiliates and the precise identity of the Cidron Savanna 4 SARL entity are not independently confirmed beyond the registry record and reasonable inference from public deal disclosures.

Sources

  • Danish Business Authority β€” CVR (Central Business Register), https://datacvr.virk.dk, register data synced 15 September 2026
  • LEO Foundation, "Ownership," https://leo-foundation.org/en/ownership/, retrieved 16 September 2026
  • Nordic Capital, press release, 23 March 2021, https://www.nordiccapital.com/insights/press-releases/leo-foundation-and-nordic-capital-partner-up-to-further-strengthen-leo-pharma-s-leading-position-in-medical-dermatology/
  • LEO Foundation, "The LEO Foundation announces closing of Nordic Capital’s investment in LEO Pharma," 22 July 2021, https://leo-foundation.org/en/2021/07/22/the-leo-foundation-announces-closing-of-nordic-capitals-investment-in-leo-pharma/

Registry feed — rows exactly as filed with Danish Business Authority β€” CVR (Central Business Register), including entries the profile above does not cover.

Ultimate HQ
Leo Fondet
Denmark
Leo Pharma AS
NorwayNO 946397369

LEO LABORATORIES LIMITED
IrelandIE 16885

Leo Pharma Inc.
United StatesUS NJ 4724539

LEO PHARMA SPA
ItalyIT IT11271521004

LEO PHARMA K.K.
JapanJP 4010001134016

Lovens Kemiske Fabriks Handelsaktieselskab
DenmarkDK 24238113

LEO Pharma s.r.o.+ subsidiaries
CzechiaCZ 24719641

Leo Pharma
BelgiumBE BE0404780604

+21 more entities

Registry questions

Frequently asked questions

What does LEO PHARMA A/S do?

LEO Pharma A/S is a Danish pharmaceutical company specialising in medical dermatology, researching, manufacturing and marketing treatments for skin conditions such as psoriasis and actinic keratosis, and distributing products in more than 100 countries.

Who owns LEO PHARMA A/S?

Per the Danish CVR register, LEO Holding A/S holds 81.77% and Cidron Savanna 4 SARL holds 18.23% of LEO Pharma A/S, as of data verified 14 September 2026.

Who is LEO PHARMA A/S's UBO (Ultimate Beneficial Owner)?

The Danish CVR register lists Karin Jexner Hamberg and Anja Boisen as registered beneficial owners ("Reelle ejere") of LEO Pharma A/S, without a disclosed effective ownership percentage.

What is LEO PHARMA A/S's company registration number?

LEO PHARMA A/S's registration number is 56759514, filed with Danish Business Authority β€” CVR (Central Business Register) in Denmark. Its current status on the register is active.

Is LEO PHARMA A/S still an active company?

LEO PHARMA A/S's status on Danish Business Authority β€” CVR (Central Business Register) is listed as active.

When was LEO PHARMA A/S incorporated?

LEO PHARMA A/S was incorporated on 10 February 1962, according to Danish Business Authority β€” CVR (Central Business Register).

What is LEO PHARMA A/S's registered address?

The registered address on file for LEO PHARMA A/S is Ballerup, Denmark.

What is LEO PHARMA A/S's revenue?

LEO Pharma's wider group reported consolidated revenue of DKK 12,453 million for the 2024 financial year, per the company's own 2024 annual results announcement; this is a group-level figure, not a standalone LEO Pharma A/S entity figure.

Is LEO PHARMA A/S listed on a stock exchange?

LEO Pharma A/S is privately held and is not listed on any stock exchange.

Who are the officers/directors of LEO PHARMA A/S?

Jesper Brandgaard has served as Chairman of the Board of Directors of LEO Pharma since 1 August 2021; Christophe Bourdon has served as Chief Executive Officer since 1 April 2022, per LEO Pharma's and LEO Foundation's official disclosures.

Does LEO PHARMA A/S have a parent company or subsidiaries?

LEO Pharma A/S is ultimately owned by Leo Fondet (the LEO Foundation), a Danish enterprise foundation, via the intermediate holding company LEO Holding A/S, with a minority stake held by Cidron Savanna 4 SARL linked to Nordic Capital's 2021 investment.

Other companies in Denmark

All companies in Denmark

This website uses cookies to improve your web experience.